shipping aligned with Stability Studies guidelines.

When Should Training Occur?

Staff training should ideally be conducted during the Site Initiation Visit (SIV). This training must be completed before the First Patient In (FPI) and should be repeated whenever there is:

• A protocol amendment
• New staff onboarding
• Recurring protocol deviations
• Inspection or audit findings that mandate retraining

Key Components of Site Staff Training:

1. Protocol Training

• Primary and secondary endpoints
• Inclusion/exclusion criteria
• Visit schedules and window flexibility
• Concomitant medications and prohibited treatments

2. Informed Consent Process (ICP)

• Legally acceptable representative involvement
• ICF version control and documentation
• Re-consenting due to amendments

3. Adverse Event (AE/SAE) Reporting

• Reporting timelines (24-hour/7-day rules)
• Use of MedDRA coding and narrative writing
• Safety communication pathways

4. Investigational Product (IP) Handling

• Storage conditions, temperature logs, expiry date monitoring
• Accountability logs and return/destruction procedures
• Blinding integrity and emergency unblinding protocols

5. Electronic Data Capture (EDC) Training

• Role-based system access and login credentials
• Query management and data entry best practices
• Audit trail review and system compliance

6. Regulatory and GCP Training

• Overview of ICH-GCP E6(R2)
• Sponsor and CRO SOPs
• Documentation expectations in the ISF/eISF

Training Methods and Formats

Choose a format that aligns with your site’s capability and sponsor requirements:

• In-Person Training: Conducted during the on-site SIV; allows hands-on interaction and team engagement.
• Remote Training: Via Zoom/Teams with shared screen protocols and quizzes; effective for hybrid trials.
• Self-Paced Modules: Sponsor-provided e-learning platforms with quizzes, ideal for re-training.
• Hybrid: A combination of online protocol walkthroughs with onsite verification of IP and documents.

Documentation Requirements

All training activities must be documented to ensure audit readiness:

• Signed and dated training logs per staff member
• Attendance records with timestamps
• Certificates of completion (for GCP/e-learning)
• Training material (slides, quizzes, checklists) archived in TMF

Use standardized templates from Pharma SOP documentation to streamline record-keeping and ensure uniformity.

Regulatory Considerations

According to Health Canada and global regulatory bodies:

• Site staff must be adequately trained before trial start and re-trained for major changes
• Training records should be accessible for audits and inspections
• Training must align with ICH-GCP and national regulations

Best Practices for Effective Training:

1. Customize training to site-specific roles and responsibilities
2. Include real-life protocol scenarios and role-play activities
3. Use quizzes to reinforce retention and flag areas needing review
4. Conduct refresher training at regular intervals
5. Monitor effectiveness via early site performance and protocol adherence

Common Pitfalls and How to Avoid Them

• Training overload: Break sessions into smaller modules to avoid fatigue.
• Poor documentation: Assign a CRC or QA member to track training logs.
• PI disengagement: Make PI training mandatory and interactive.
• Skipping re-training: Schedule retraining at set intervals or trigger-based events.

Conclusion

Effective training during the initiation phase is the backbone of successful clinical trial execution. It reduces variability, enhances staff confidence, and supports compliance with GCP and sponsor requirements. By implementing structured, role-specific training using SOP-aligned materials, sponsors can ensure every member of the site team is equipped to deliver high-quality data and patient safety. Invest in training early—and the benefits will be reflected throughout your study lifecycle.